Member Info for Sagetrade

Great post - keep the detailed insight coming sizey. Valued member of the investment community you.

Surely everyone has realised by now that this clown is nothing more than a charlatan and shyster?! Close call who has less credibility left out of him and AS.

As a reminder, and I quote, verbatim:

"it's a given AVCT announces a licensing deal or collaboration with one of the worlds largest pharma companies, in the next week or three" (19/12/2023).

Absolute con artist - clueless PI's need to stop hanging off his every word....

Waggy - you're posting history on this stock is something to behold...! Are you bipolar?

I'm usually getting called a troll etc from the goons on this board, but honestly, are you okay fella?

One minute this is the best investment on AIM, the next we're about to enter liquidation.

You're either mentally ill, or have an underhand agenda at play here....

Think you'll find quite a few holders would be pretty happy with a £2 takeover bid right now (400% premium to current valuation I might add, and hence never going to happen whilst we're languishing down here!)

Obviously not - as signing of Heads would clearly need an RNS.

Is another nod to the fact Avacta are far from the only horse at this race though!

Typical incoherent nonsense. Do you actually believe that drivel? You are honestly one of the thickest individuals I’ve ever come across

Would you like to apologise to me cj?

Sounds sensible Steve, any chance you’re running an investing masterclass soon?

I look forward to that day CJ, I really do. then, I’ll offer my view of the current situation based on what’s in front of me. Cheers.

“Avacta owns good funding”

“When the RNS arrives, the public will see the reality of this amazing platform”

What planet are these people on?! Joe Bloggs public haven’t got a clue what AZ and the likes are doing, let alone what a tiny AIM Biotech is up to!

Yes, you got me...rumbled.

Jeez, some total and utter wallies on here. Off for another hiatus with my imaginary friend Eliot.

FYI, this is what I posted on here in Oct 22. Do you see the irony? Myles talks and the sheep follow.

"How does Al sell this as shareholder value?? They’ve just paid over 20x EBITDA on day1 for a tiny diagnostics business. Fair play to the sell side CF advisors, sounds like a stonking deal for Coris!"

@EliotF

As I say, I rarely frequent this board, so have no clue what Eggy or anyone else is saying.

Due to Mr Musks algorithms, anything Myles etc post usually appears near the top of my timeline, hence the visibility.

Given his audience (which he's acutely aware of) I think it's very fair to question and critique claims such as , and I quote, "for me, it's a given AVCT announces a licensing deal or collaboration with one of the worlds largest pharma companies, in the next week or three" (19/12/2023).

Re your Dx point - we're actually a little over a year (Oct 22) since the Launch acq news.

Do I agree Dx should be sold - probably

But then again, I said diagnostics M&A was a poor idea at the time, and yes you guessed it - was shot down for it whilst the likes of Myles, RAH et all lapped it up as a great, derisking move whilst also telling us all how great it was that Heights Capital were now on board as an II!!!

You can see the hypocrisy here, and where I'm coming from! Some people have very short memories.

@cj62 - exactly my point.

Im invested here and have been for several years.

I think it’s a great opportunity and believe in it wholeheartedly medium - long term.

However, I have and do find some of the outlandish claims around SP, imminent takeovers etc etc etc incredibly tiresome. It was the same during LFT gate re how we were going to awarded 8 figure contracts next week etc etc etc.

I (and others) have also questioned the commercial acumen and strategy of the BOD on several occasions and been lambasted/blocked etc at each and every turn.

Hence the irony of seeing Rah et all now pivot into the same opinion…..

Fair points DTW…well put.

I still however think it’s more than justifiable to question and critique outlandish claims like the one I mentioned.

EliotF - re “eggy” - as you said yourself I post on here very occasionally so am not exactly up to date on the daily rumblings….

Suppose what I was getting at is that anyone who dares question anything is (was) usually shouted down as not invested / shorting etc etc which I find nonsense and invariably un true.

Anyway, I'm off now for another 3 months .

I’ll respond to your points, would you like to respond to mine now?

Do you not see the absolute hilarity of claiming a license deal is about to hit, and then 5 weeks later stating with a straight face that you’d instead be happy to fund cash runway with £20m (£10m loss) for selling dx?

I think they’re both invested, I also think Myles manipulates his position to manufacture entry and exit positions.

What’s your point?

If people (Myles) want to make outlandish claims that “it’s a given a license deal with major pharma is going to land in the next week or 3”, do you not think that is open to challenge, and indeed ridicule? I find it beyond parody that their integrity isn’t questioned in the slightest by the sheep on here.

It’s at best deceptive.

Once again, the hysteria to any perceived negativity (reality) is comical.

Nail on the head Thornogson.

Another DE or MTD does nothing material to the pattern we’re currently in, especially given the funding.

Will take proper commercial news (licensing or the like) for this to reach anything close to a £bn valuation. I think that will happen, just not anytime soon.

(No doubt be shouted down as per, by the rampers that have been so consistently and horribly wrong wrt to this stock and SP predictions for several years now).

Why is it then strangy? Enlighten us all? What delusions of grandeur are we going with now? Is it “MM’s playing games”, or “collecting stock for a big order” or “keeping the price down for a TO bid”.

It’s nonsense, simple fact is SP will go down when more sellers than buyers, and there’s clearly someone offloading large amounts of stock on a semi regular basis for a while now ie HCI.

Is always the issue with convertible debt. If there isn’t strong regular news flow to support share price increases, this is what happens.

Wasn’t long ago Myles was labelling Heights as fantastic II’s and exactly the sort of investor we needed.

Lolz.

All due to the HC convertible debt. #deathspiral